American Portfolios Advisors Lumos Pharma, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 1,250 shares of LUMO stock, worth $5,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,250Holding current value
$5,425% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUMO
# of Institutions
6Shares Held
168KCall Options Held
0Put Options Held
0-
Jefferies Group LLC New York, NY121KShares$523,6250.01% of portfolio
-
Black Rock Inc. New York, NY41.1KShares$178,3910.0% of portfolio
-
Urban Wealth Management, LLC3.49KShares$15,1460.09% of portfolio
-
Wipfli Financial Advisors Llc,1.01KShares$4,3870.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ100Shares$4340.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...